These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 545666)

  • 1. Heating at 56 degrees C does not eliminate immune complex-bound Clq.
    Teppo AM; Wager O
    Scand J Immunol; 1979; 10(5):431-5. PubMed ID: 545666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.
    Zubler RH; Lange G; Lambert PH; Miescher PA
    J Immunol; 1976 Jan; 116(1):232-5. PubMed ID: 1245740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on circulating immune complexes of the liver disease. 3. Conditions for Clq binding assay and low molecular weight Clq reactants.
    Arima T; Narumoto J; Shimomura H; Suwaki K; Kunishi K; Yasuhara T; Nagashima H
    Gastroenterol Jpn; 1980; 15(1):20-6. PubMed ID: 6153627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of aggregated human gamma globulin by Raji cells: C1q will enhance only if it is dissociated from the C1 macromolecular complex.
    Manthei U; Strunk RC
    Immunology; 1981 Jun; 43(2):287-92. PubMed ID: 6166545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor.
    Gabriel A; Agnello V
    J Clin Invest; 1977 May; 59(5):990-1001. PubMed ID: 323292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue immune complexes demonstrated in the liver of patients with chronic aggressive hepatitis using FITC-labelled human Clq.
    Tsuji T; Araki K; Inoue J; Onoue K; Tsuchiya M; Shinohara T; Nagashima H; Nakashima A; Naito K; Arborgh B
    Acta Med Okayama; 1980 Jun; 34(3):209-16. PubMed ID: 6447990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of immune complexes by an equine Clq-like factor.
    McDonald TL
    Immunol Commun; 1981; 10(8):741-52. PubMed ID: 6176533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.
    Teshima H; Wanebo H; Pinsky C; Day NK
    J Clin Invest; 1977 Jun; 59(6):1134-42. PubMed ID: 325016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of age on the character of immune complex disease: a comparison of the incidence and relative size of materials reactive with Clq in sera of patients with glomerulonephritis and cancer.
    Rossen RD; Reisberg MA; Singer D; Suki WN; Duffy J; Hersh EM; Schloeder FX; Hill LL; Eknoyan G
    Medicine (Baltimore); 1979 Jan; 58(1):65-79. PubMed ID: 154003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the interaction between the complement component Clq and immune complexes.
    Allan R; Rodrick M; Knobel HR; Isliker H
    Int Arch Allergy Appl Immunol; 1979; 58(2):140-8. PubMed ID: 33905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepancy between Clq deviation and Raji cell tests in detection of circulating immune complexes in patients with leprosy.
    Tung KS; Kim B; Bjorvatn B; Kronvall G; McLaren LC; Williams RC
    J Infect Dis; 1977 Aug; 136(2):216-21. PubMed ID: 330768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating immune complexes in patients with lung cancer.
    Lowe J; Segal-Eiras A; Iles PB; Baldwin RW
    Thorax; 1981 Jan; 36(1):56-9. PubMed ID: 7292383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of the subunit Clq from the first component of equine complement.
    McDonald TL; Burger D
    Immunology; 1979 Jul; 37(3):517-27. PubMed ID: 91570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of circulating immune complexes by immunoenzyme assay with solid phase Clq].
    Mezzano S; López MI
    Rev Med Chil; 1984 Jun; 112(6):547-52. PubMed ID: 6393265
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating Clq binding complexes in inflammatory bowel diseases.
    Einstein E; Charland C; Thayer WR
    Digestion; 1979; 19(1):65-9. PubMed ID: 456771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and plasma fibronectin binds to complement reacted immune complexes primarily via Clq.
    Baatrup G; Svehag SE
    Scand J Immunol; 1986 Nov; 24(5):583-90. PubMed ID: 3097811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating immune complexes in African mothers and their newborns.
    Reinhardt MC; Zubler RH; Lambert PH
    Helv Paediatr Acta Suppl; 1978 Dec; (41):111-6. PubMed ID: 215572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serial measurements of circulating immune complexes in acute poststreptococcal glomerulonephritis by 125I-Clq binding test (author's transl)].
    Yoshizawa N; Fujita K
    Nihon Jinzo Gakkai Shi; 1979 May; 21(5):479-92. PubMed ID: 529618
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody to a cryptic, solid phase C1Q antigen in membranoproliferative nephritis.
    Strife CF; Leahy AE; West CD
    Kidney Int; 1989 Mar; 35(3):836-42. PubMed ID: 2785226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibronectin associated with Clq in a Clq isolation procedure.
    Anderson B; Entwistle R; Puyat L; Davis L; Schmid FR
    Immunol Commun; 1981; 10(8):687-96. PubMed ID: 6804372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.